Penile Lengthening Surgery in India and UAE | Complete Patient Guide

• WHO IS A CANDIDATE:

• Men with objectively measured stretched penile length (SPL) below 9 cm (micropenis) or below personal pre-morbid length following radical prostatectomy, Peyronie's disease, or pelvic trauma

• Men with penile dysmorphic disorder confirmed by structured psychiatric/psychosexual evaluation (PHQ-9 depression screen, BDDQ-DV questionnaire, IIEF-5 erectile function score)

• Men who have completed ≥6 months of first-line penile traction therapy without satisfactory outcome

• Age ≥18 years with fully developed secondary sexual characteristics; BMI ideally <30 kg/m² (high pubic fat pad reduces apparent external length and should be addressed via concurrent pubic liposuction if present)

• Stable erectile function (IIEF-5 score ≥17) or concurrent erectile dysfunction being managed separately with PDE-5 inhibitors (tadalafil, sildenafil) or intracavernosal alprostadil therapy

• REQUIRED PRE-OPERATIVE DIAGNOSTICS:

• Stretched penile length (SPL) and mid-shaft circumference measurement by calibrated technique (gold standard: Wessells method)

• High-resolution penile duplex Doppler ultrasonography (peak systolic velocity, end-diastolic velocity, resistive index) to map cavernosal arterial anatomy and exclude veno-occlusive dysfunction

• Hormonal panel: Total testosterone, free testosterone, LH, FSH, prolactin, SHBG (hypogonadism exacerbates psychosexual distress and must be corrected before surgery)

• Full blood count, coagulation profile (PT, aPTT, INR), HbA1c, fasting glucose (diabetes increases infection and wound-healing risk)

• STI/BBV screen: HIV, HBsAg, HCV, syphilis serology

• Pelvic MRI with gadolinium contrast in post-Peyronie's or post-prostatectomy cases

• Psychological/psychosexual clearance letter from a licensed mental health professional

• Anaesthesia fitness assessment: ECG, chest X-ray, spirometry if BMI >30 or age >45

• ABSOLUTE CONTRAINDICATIONS:

• Active genitourinary infection or sexually transmitted infection

• Uncontrolled diabetes mellitus (HbA1c >9%)

• Active psychiatric disorder not cleared by psychiatrist

• Penile cancer or undiagnosed penile lesions

• Coagulopathy or ongoing anticoagulation therapy not bridgeable

• Unrealistic expectations not resolved after mandatory psychosexual counselling

• RELATIVE CONTRAINDICATIONS:

• Severe erectile dysfunction (IIEF-5 <11) — requires concurrent vascular workup and possible penile prosthesis planning

• BMI >35 kg/m² — significantly increases anaesthetic risk and reduces surgical field access

• Peyronie's disease with active inflammatory phase (pain on erection) — surgery deferred until disease stabilises

TECHNIQUE 1 — SUSPENSORY LIGAMENT RELEASE (LIGAMENTOLYSIS) WITH SKIN ADVANCEMENT FLAP

The established gold-standard for flaccid length augmentation. Under spinal or general anaesthesia, a suprapubic or inverted-V incision exposes the fundiform and suspensory ligaments, which are sharply divided at their pubic symphysis attachment. The corpora cavernosa are mobilised and a V-Y advancement plasty — or alternatively a double Z-plasty — is executed at the penopubic junction to advance penile shaft skin distally, covering the newly externalised segment and preventing scar retraction. Mean flaccid length gain: 1.5–3.0 cm. Operative time: 60–90 minutes. This technique does NOT increase erect length and patients must be counselled explicitly on this distinction. Post-operative penile traction therapy (4–8 hours/day for 6 months) is mandatory to consolidate gain.

TECHNIQUE 2 — AUTOLOGOUS FAT TRANSFER (LIPOFILLING) FOR GIRTH ENHANCEMENT

Pure fat is harvested via micro-cannula liposuction from the abdomen or inner thigh, processed by centrifugation (Coleman technique) or filtration, and injected circumferentially into the sub-dartos plane of the penile shaft using blunt-tip micro-cannulas. Nano-fat fractions rich in adipose-derived stromal cells (ADSCs) are increasingly used in combination to improve graft survival. Expected girth gain: 1.5–2.5 cm circumference. Absorption rate: 30–50% at 12 months, necessitating a planned second session in many patients. The procedure is performed as day surgery under local anaesthesia with IV sedation and carries no incision scar on the penis itself.

TECHNIQUE 3 — ALLOGRAFT DERMAL MATRIX WRAPPING

Acellular dermal matrix allografts (e.g., Alloderm, MegaDerm) are surgically placed as a circumferential subcutaneous sleeve around the shaft corpora after degloving the penile skin under general anaesthesia. This provides more durable and uniform girth enhancement than fat transfer (absorption rate <15%) but requires a full penile degloving incision and carries higher complication risk including infection, implant exposure, and altered penile sensation. Indicated primarily in patients requiring revision after fat absorption or in post-traumatic reconstruction cases.

TECHNIQUE 4 — HYALURONIC ACID (HA) FILLER INJECTION

Minimally invasive, office-based procedure using high-density cross-linked HA filler (e.g., Juvederm Voluma, Restylane Lyft) injected into the sub-dartos space via a blunt cannula. No anaesthesia beyond topical EMLA cream required. Duration of effect: 12–18 months. Reversible with hyaluronidase injection. Not recommended as a primary treatment by ISSM guidelines but appropriate for patients declining surgery or seeking temporary augmentation before committing to a permanent procedure. Risk of nodule formation and irregular distribution is technique-dependent.

TECHNIQUE 5 — PENILE IMPLANT WITH LENGTH RESTORATION (INFLATABLE PENILE PROSTHESIS — IPP) IN ERECTILE DYSFUNCTION CASES

For men with concurrent severe erectile dysfunction (post-radical prostatectomy, Peyronie's disease with calcified plaque), a 3-piece inflatable penile prosthesis (AMS 700 CX, Coloplast Titan) simultaneously restores erectile function and, via intraoperative manual traction and rear tip extender (RTE) selection, maximises functional penile length. This is a distinct surgical goal from cosmetic lengthening and is governed by separate EAU/AUA guidelines. Robotic-assisted perineal IPP implantation is now available at select premium centres in India and the UAE, reducing infection rates compared to open technique via the Inhibizone antibiotic-coated prosthesis platform.

COMPARATIVE SUMMARY:

• Most effective for flaccid length gain: Ligamentolysis + V-Y plasty

• Most effective for girth: Allograft dermal matrix > Autologous fat transfer > HA filler

• Least invasive: HA filler injection

• Best for ED + shortening: Inflatable penile prosthesis with RTEs

• All techniques must be combined with structured penile traction therapy and psychosexual follow-up for optimal outcomes

PHASE 1 — PRE-TRAVEL PREPARATION (4–8 weeks before travel)

• Step 1: Submit medical records, SPL measurements, and psychosexual evaluation report to GAF Healthcare's clinical coordinator via the secure patient portal. A GAF-affiliated urologist or reconstructive surgeon conducts a telemedicine video consultation to confirm candidacy and recommend technique.

• Step 2: GAF Healthcare initiates e-Medical Visa application for India (typically approved within 3–5 business days) or visa-on-arrival/UAE entry visa coordination for Dubai/Abu Dhabi.

• Step 3: Locally arranged pre-operative blood tests (FBC, coagulation, HbA1c, hormones, STI screen, penile Doppler ultrasound) are reviewed by the operating surgeon. Any hormonal deficiencies (e.g., low testosterone) are corrected with testosterone replacement therapy before proceeding.

• Step 4: Medications to cease: aspirin and NSAIDs 10 days pre-operatively; anticoagulants per surgeon instruction with GP coordination; herbal supplements (vitamin E, fish oil, ginkgo) 2 weeks pre-operatively.

• Step 5: Patient arranges travel with one trusted companion/attendant (strongly advised for post-operative care during hotel recovery).

PHASE 2 — ARRIVAL & PRE-OPERATIVE ASSESSMENT (Days 1–2 in destination country)

• Day 1: Airport pickup by GAF Healthcare's dedicated driver. Check-in to partner accommodation (hospital guest house or 3–5 star hotel with negotiated medical rates).

• Day 2: Hospital admission for final pre-operative workup — anaesthesia fitness review, NPO (nil-by-mouth) instruction, penile marking under surgeon supervision, informed consent in patient's preferred language via GAF's medical interpreter.

PHASE 3 — SURGICAL PROCEDURE (Day 3)

• Operating time: 45–120 minutes depending on technique (ligamentolysis alone: ~60 min; combined ligamentolysis + fat transfer: ~120 min).

• Anaesthesia: Spinal anaesthesia preferred for isolated ligamentolysis (faster recovery, less nausea); general anaesthesia for combined procedures.

• Intraoperative: Suprapubic/inverted-V incision → ligament division → V-Y or Z-plasty skin advancement → closure with absorbable sutures. Compressive dressing applied. Foley catheter placed intraoperatively and removed same-day or next morning.

• Hospital stay: 1 night (or day-surgery discharge 4–6 hours post-procedure for isolated fat transfer or HA injection).

PHASE 4 — IMMEDIATE POST-OPERATIVE RECOVERY IN-COUNTRY (Days 3–21)

• Day 3–5: Rest in accommodation. Wound dressing change at hospital on Day 3. Ice packs to pubic area for swelling. Oral antibiotics (cephalexin 500 mg QDS or co-amoxiclav 625 mg TDS for 7 days), anti-inflammatory analgesia (ibuprofen 400 mg TDS), and stool softeners to prevent straining.

• Day 7: First formal post-operative review — wound inspection, suture check, haematoma/seroma screening by clinical nurse specialist.

• Day 10–14: Penile traction therapy commenced using a physician-prescribed medical-grade device (e.g., Andropenis Gold). Instruction session provided by GAF's clinical coordinator.

• MILESTONE — FIT TO FLY: Surgeon clearance issued at Day 14 for short-haul flights (<4 hours) or Day 21 for long-haul international travel. Criteria: intact wound healing, no signs of infection, haematoma resolved, patient able to walk comfortably without assistance.

PHASE 5 — LONG-TERM RECOVERY AT HOME (Weeks 3–26)

• Week 3–4: Return to sedentary desk work. Avoid strenuous lower-body exercise, cycling, or any activity causing penile compression.

• Week 6: Full return to physical activity and exercise (except sexual intercourse and penile traction during intercourse).

• Week 6–8: Sexual intercourse may resume — surgeon must provide explicit clearance.

• Month 3: First follow-up telemedicine review with GAF-affiliated surgeon. SPL re-measurement. Traction compliance assessed.

• Month 6: Final outcome assessment. SPL measurement compared to baseline. Psychosexual well-being reviewed. Second fat transfer session planned if absorption warrants.

• Month 6+: Traction therapy may be tapered. Maintenance penile exercise protocols continue indefinitely.